MedPath

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

Phase 4
Completed
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
Behavioral: Written education material (basic)
Behavioral: Additional education material
Behavioral: PELICAN-Reactive
Behavioral: PELICAN-Proactive
Registration Number
NCT02098369
Lead Sponsor
University of Illinois at Chicago
Brief Summary

About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).

Detailed Description

The COPD Foundation operates a peer-led telephone-based information line, but its effectiveness in promoting adherence to O2 therapy and patient-centered outcomes is unknown. Our overall hypothesis is that a patient-centered Peer-Led O2 InfoLine for patients and CAregivers (PELICAN) will increase adherence and improve health. We have developed a broad-based collaboration with patients/caregivers, advocacy groups, a national O2 supplier, and others to conduct a 3-arm pragmatic clinical trial, to evaluate the comparative effectiveness of proactive vs. reactive PELICAN interventions vs. usual care on adherence to O2 (primary outcome) and on other patient-centered outcomes (secondary outcomes).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
444
Inclusion Criteria
  1. Age 18 years or older.
  2. Physician diagnosis of COPD
  3. Physician prescription for home O2 for 24hrs/day, 7 days/week
  4. Willing to use home O2.
  5. Working telephone number.
Exclusion Criteria
  1. Unable to read and speak English.
  2. Discharge to home hospice or expected survival less than 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ReactiveWritten education material (basic)Written education material (basic) Additional education material PELICAN-Reactive \[In addition to the usual care, participants will receive educational material and a reactive telephone peer coaching program (participants call coaches)\]
ReactiveAdditional education materialWritten education material (basic) Additional education material PELICAN-Reactive \[In addition to the usual care, participants will receive educational material and a reactive telephone peer coaching program (participants call coaches)\]
ProactiveAdditional education materialWritten education material (basic) Additional education material PELICAN-Proactive \[In addition to the usual care, participants will receive educational material and a proactive telephone peer coaching program (coaches call participants)\]
ProactiveWritten education material (basic)Written education material (basic) Additional education material PELICAN-Proactive \[In addition to the usual care, participants will receive educational material and a proactive telephone peer coaching program (coaches call participants)\]
ReactivePELICAN-ReactiveWritten education material (basic) Additional education material PELICAN-Reactive \[In addition to the usual care, participants will receive educational material and a reactive telephone peer coaching program (participants call coaches)\]
Usual careWritten education material (basic)Written education material (basic)
ProactivePELICAN-ProactiveWritten education material (basic) Additional education material PELICAN-Proactive \[In addition to the usual care, participants will receive educational material and a proactive telephone peer coaching program (coaches call participants)\]
Primary Outcome Measures
NameTimeMethod
Adherence to Supplemental O2 Prescription60 days

Number of individuals who used the stationary concentrator for a mean of at least 17.7 hours per day

Secondary Outcome Measures
NameTimeMethod
PROMIS - Satisfaction With Social Roles and Activities60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less satisfaction with social roles and activities.)

PROMIS - Physical Function60 days

Change in T-score from baseline to day 60. (A negative change in score indicates worse physical functioning.)

PROMIS - Fatigue60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less fatigue.)

PROMIS - Emotional Distress - Anxiety60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less emotional distress - anxiety.)

PROMIS - Sleep Disturbance60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less sleep disturbance.)

PROMIS - Emotional Distress - Depression60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less emotional distress - depression.)

PROMIS - Ability to Participate in Social Roles and Activities60 days

Change in T-score from baseline to day 60. (A negative change in score indicates less ability to participate in social roles and activities.)

Trial Locations

Locations (6)

Apria Healthcare

🇺🇸

Lake Forest, California, United States

National Jewish Health

🇺🇸

Denver, Colorado, United States

University of Illinois Hospital

🇺🇸

Chicago, Illinois, United States

AlphaNet

🇺🇸

Miami, Florida, United States

COPD Foundation

🇺🇸

Miami, Florida, United States

Los Angeles Biomedical Research Institute

🇺🇸

Torrance, California, United States

© Copyright 2025. All Rights Reserved by MedPath